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Abstract: This article identifies the main challenges of the National Health Service of Spain and
proposes its transformation into a Learning Health System. For this purpose, the main indicators
and reports published by the Spanish Ministries of Health and Finance, Organization for Economic
Co-operation and Development (OECD) and World Health Organization (WHO) were reviewed.
The Learning Health System proposal is based on some sections of an unpublished report, written by
two of the authors under request of the Ministry of Health of Spain on Big Data for the National Health
System. The main challenges identified are the rising old age dependency ratio; health expenditure
pressures and the likely increase of out-of-pocket expenditure; drug expenditures, both retail
and consumed in hospitals; waiting lists for surgery; potentially preventable hospital admissions;
and the use of electronic health record (EHR) data to fulfil national health information and research
objectives. To improve its efficacy, efficiency, and quality, the National Health Service of Spain should
be transformed into a Learning Health System. Information and communication technologies (IT)
enablers are a fundamental tool to address the complexity and vastness of health data as well as the
urgency that clinical and management decisions require. Big Data solutions are a perfect match for
that problem in health systems.
Keywords: learning health system; Big Data applied to healthcare; Big Data applied to clinical
research; data protection; patient’s phenotyping; Big Data applied to National Health System of Spain
1. Introduction
1.1. Health Systems’ Challenges
Health systems in western European countries currently deal with several serious challenges,
such as population aging, increasing impact of chronic diseases, rising demand on healthcare services,
the process of continuous innovation that brings expensive new healthcare technologies, and, as a result
of all of these, an increase in public expenditure that must coexist with the corresponding budget
constraints. Moreover, western healthcare systems present some shortcomings which cannot be
addressed exclusively by advances in science: failure to address preventable diseases; low safety
level of patients; unwanted variations in quality of care; lack of efficiency in the use of resources;
and inequity in treatment access and results. These deficiencies contribute to the growth of public
health expenditure and have a high social cost, which comes at the same time as a lower public outlay,
in both gross as well as percentage points of the GDP [1].
Quality, efficiency, and effectiveness enhancement demands that health systems focus on the
needs and preferences of individual patients, and not on patients as an abstract concept. Therefore,
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there must be specific, measurable, and personally meaningful goals for each patient. This means they
must have clinical and individual value for each person. In medical terms, value can be defined as
a clinical status improvement, including the quality of life of each patient [2]. Medical communication
and technical quality of care, accessibility and physical environment satisfaction, interpersonal manner,
and empathy are some of the dimensions that should be measured [3].
1.2. Information and Communication Technologies Are the Tool to Transform Health System
The aforementioned challenges require health systems to increase their effectiveness and efficiency.
This process must rely heavily on information and communication technologies (IT), since any
healthcare activity needs an intensive processing of information. IT brings improvements in efficiency
and quality of operations management in health systems by reducing operating costs of clinical services,
reducing administrative costs, and transforming healthcare. IT implementation can result in care
that is both higher in quality, safer, and more responsive to patients’ needs and, at the same time,
more efficient (appropriate, available, and less wasteful) [4].
Improving the effectiveness and efficiency of the process requires acquiring and applying new
knowledge. Health systems generate knowledge and produce data which, if duly analyzed, will create
new knowledge. This knowledge management includes the practice of data mining, which can be
highly beneficial for improving health systems. Therefore, generating value in the health system should
be based on taking advantage of existing and created (by the system) knowledge. As a rule of thumb,
everything that does not generate value is a cost, and must be eliminated.
Health data constitutes a significant resource and it makes economic and ethical sense to use
this data as much as possible to improve the health of the population and the effectiveness, safety,
and patient-centeredness of healthcare systems. Rising levels of chronic disease and multi-morbidity,
concerns about the quality and safety of patient care, the need to measure and assure value for money
for investments in health, and the need to allocate health system resources require good evidence for
decision making (Figure 1) [5].
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and accurate patient data that ensure continuity in care, including health outcomes and costs. Such data
also support the re-design and evaluation of new models of healthcare service delivery and contribute
to the discovery and evaluation of new treatments [6].
1.3. Objectives
This article has three purposes:
1. Identify the current challenges of the Spanish National Health System.
2. Propose a new Big Data based solution which will improve the quality, efficiency, and effectiveness
of the Spanish National Health System to address these challenges. This process needs to use
both clinical and non-clinical data to aid the decision-making processes related to patients’ health,
research, and evaluation of the performance of the health system. The governance, architecture,
legal framework, bioethical principles, data homogeneity, and technological tools needed for its
creation, operation, and evolution must also be considered.
3. Propose the creation of a Learning Health System (LHS) for the National Health System of Spain,
envisioned as an integrated framework “in which progress in science, informatics, and care
culture align to generate new knowledge as an ongoing, natural by-product of the care experience,
and seamlessly refine and deliver best practices for continuous improvement in health and
healthcare” [7].
2. Materials and Methods
To identify the Spanish National Health System current challenges and analyze its performance,
statistics and reports from the Spanish Ministry of Health, the Spanish National Statistics Institute,
the Spanish Ministry of Finance and the Organization for Economic Co-operation and Development
(OECD) were studied, as well as the reports provided by the National Health System Observatory
(Ministry of Health). The selected dataset analyzed relates to dependence, life expectancy, mortality,
chronic diseases (preventable hospitalizations) health, and pharmaceutical expenditure. In addition,
reports from the OECD and World Health Organization (WHO) showing efficiency, Big Data and IT
usage in health systems have been considered. In all cases results obtained in Spain were compared
with those reported by the European Union (EU) and the OECD member countries. The progress in
national dataset availability and health data governance based on OECD reports was also reviewed.
The Learning Health System proposal is based on the sections of an unpublished Big Data for
the National Health System report written by two of the authors under request of the Ministry of
Health of Spain.
Moreover, non-systematic searches in the PubMed database using the key words “Big Data
and Health” and “Big Data and Healthcare” have been carried out.
3. Results
In Spain, the National Health System provides universal care and is funded by the government via
taxes. The management of the healthcare services, as part of the National Health System, is decentralized,
relying on each Regional Government, although the Ministry of Health is responsible for the systems
and information technologies shared by all the health services. An Inter-territorial Board of the National
Health System oversees the coordination between the healthcare providers in which all the 17 regions
take part. Such a board is tasked with acquiring knowledge, debating, and advising on the essential
functions of the National Health System, and planning, coordinating, and evaluating its performance.
The National Health System of Spain is considered as one of the top performing ones in terms of
outputs, such as life expectancy, as well as performance, defined as the best result that can be obtained
with an equal amount of resources. The World Health Organization ranked it as the seventh best
performing country among 191 countries in a report published in the year 2000 [8].
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Table 1 summarizes the main indicators obtained from the review conducted on dependence,
life expectancy, spending in healthcare, and share of avoidable admissions.
Table 1. Indicators on dependence, life expectancy, spending in healthcare and share of avoidable
admissions due to five chronic diseases.
Indicator Spain European Union
Population under 15 years old/Total population 15% 16%
Population older than 65/Total population 19.0% 19.0%
Life expectancy at birth (years) 82.8 81.0
Life expectancy at birth (women) (years) 86.3 83.6
Healthy life years (women) 66.5 64.2
Life expectancy at birth (men) (years) 80.5 78.2
Healthy life years (men) 65.9 63.5
Spending on healthcare (% GDP) 8.8 9.6
Share of total health spending financed by out-of-pocket payments 23.8% 18.2%
Pharmaceutical expenditure (retail) per capita and as a share of health expenditure 19.1% 16.8%
Pharmaceutical expenditure (retail) per capita financed by government/compulsory
schemes as a share of pharmaceutical expenditure 57% 64%
Share of potentially avoidable hospital admissions due to five chronic conditions:
diabetes, hypertension, heart failure, COPD and bronchiectasis, and asthma. 6.3% 5.5%
Source: Organization for Economic Co-operation and Development (OECD) /European Union (EU) (2018), Health at
a Glance: Europe 2018: State of Health in the EU Cycle. [9]
3.1. Dependency
The dependency ratio is the demographic index that shows as a percentage the relation between
dependent population (defined as younger than 16 and older than 64) and productive population
(between 16 and 64). This ratio can be divided between youth dependency rate (under 16) and senior
dependency rate (over 64). The dependency rate in Spain is 53.4%, comprised of a senior dependency
rate of 28.7% and a 24.7% young dependency rate [10]. In the EU, 16% of its population is under
15 years old and 19% is above 65. The country with the highest population under 15 years old is
Ireland, while Germany, with 13%, has the lowest. Spain, with 15% of its population under 15 years
old, and 19% older than 65, has an average rate (Table 1) [9].
In Spain, the population over 65 years old increased between 2003 and 2017 from 16.96% of
the total to 18.96%, while the senior dependency rate increased from 24.82% to 29.17% during those
same years. The ratio in 2019 is 29.94% (provisional) [11].
3.2. Life Expectancy at Birth and Healthy Life Expectancy
Life expectancy at birth measures the average number of years that a person can expect to live
based on current mortality rates (age-specific death rates). Life expectancy at birth in Spain in 2016 was
82.8 years, 80.0 for men and 86.3 for women, which is the highest in the EU. Between 2001 and 2015,
it increased by 3.1 years (3.7 for men and 2.5 for women). The leading causes of death continue to be
diseases of the circulatory system (which represent 29.7% of total deaths) and tumors (26.8% of total
deaths) [9,10].
Healthy life expectancy is an important indicator of population health. It indicates whether
any gains in life expectancy are lived in good health or with some health problems and disabilities.
A greater number of healthy life years generally means a healthier workforce, fewer early retirements
due to health problems, and reduced long-term care needs. The main indicator of healthy life years
used in the EU is the number of years lived free of activity limitations due to health problems (in other
words, disability-free life expectancy). The healthy life expectancy in Spain is higher than the EU
average (Table 1) [9].
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3.3. Mortality and Morbidity
The main causes of death in EU member countries are diseases of the circulatory system (38%),
malignant tumors (26%), and external causes (5%). Spain is among the EU28 countries with the
lowest rate of death from ischemic heart disease, cerebral stroke or breast cancer. The Spanish rate
of death from laryngeal cancer and windpipe and respiratory diseases is lower than the EU average.
In addition, Southern European countries—Greece, Cyprus, Malta, Italy, and Spain—jointly with the
United Kingdom are the regions showing the lowest rate of death from suicide, while Eastern European
countries (Slovenia, Latvia, Hungary, and Lithuania) have the highest suicide rates [9].
3.4. Health Expenditure
Health expenditure in Spain in 2005 was 7.7% of the total GDP and in 2017 it represented 8.8%.
Nevertheless, during 2011, 2012, and 2015, this value increased to 9.1% of the GDP, as shown in
Figure 2. The out-of-pocket expenditure increased between 2008 (2.2%) and 2017 (2.6%). However,
public expenditure decreased between 2009 (6.8%) and 2017 (6.3%).
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3.6. Pharmaceutical Expenditure
After inpatient and outpatient care, pharmaceuticals represent the third largest component of
health spending. In 2016, on average, medicines accounted for 16.8% of total health expenditure in
EU countries (excluding medicines used in hospitals), but 19.1% in Spain (Table 1). The EU average
of pharmaceuticals on a per capita basis was 416 euros, while in Spain it was over this amount
(EUR 440) [9].
Table 2 shows the relevance expenditure in drugs has within the total public health expenditure
in Spain. In 2017, 25% of the total public health spending was due to drugs.
Table 2. Public pharmaceutical expenditure as a share of National Health System 2017 1.
Indicator Spain
% Pharmaceutical expenditure (retail) 9.35
% Pharmaceutical expenditure (hospitals) 15.65
% Total pharmaceutical expenditure as a share of National Health System 25.00
1 Out-of-pocket expenditure is excluded. Source: Compiled by the authors based on Public Health Expenditure and
Pharmaceutical and Health Expenditure Statistics (Last updated: 22 April 2019). Ministry of Health and Ministry of
Finances [12,13].
3.7. Avoidable Mortality (Preventable and Amenable)
Preventable mortality is defined as deaths that could be avoided through public health and
prevention interventions, whereas amenable (or treatable) mortality is defined as deaths that could
be avoided through effective and timely healthcare. The age-standardized rate of preventable
mortality is lowest in Italy, Cyprus, and Spain, with rates at least 25% lower than the EU average.
The age-standardized rate of amenable mortality is lowest in France, Spain, and the Netherlands,
because these countries are among those with the lowest death rate from ischemic heart diseases and
cerebrovascular diseases.
3.8. Share of Potentially Avoidable Hospital Admissions Due to Five Chronic Conditions
The share of potentially avoidable hospital admissions due to five chronic conditions (diabetes,
hypertension, heart failure, chronic obstructive pulmonary disease (COPD), and bronchiectasis and
asthma is a good indicator of the performance of the health system in managing chronic diseases.
Spain’s share (6.35%) is over the EU average (5.5%) (Table 1) [9].
3.9. Waiting Times for Elective Surgery
The data presented here focus on two high-volume procedures: cataract surgery (Figure 3) and hip
replacement (Figure 4). In 2016, the average waiting time for people who underwent cataract surgery
in Spain was around three months. The waiting time for cataract surgery increased from 83 days in
2009 and 2010 to 108.6 in 2016 [9].
In 2016, the average waiting time for people who underwent hip replacement surgery in Spain
was around five months. The waiting time for hip replacement surgery increased from 117 days in
2005 to 158 in 2016. In 2011, the decreasing trend that begun in 2006 ceased and the waiting time
started increasing [9].
Processes 2019, 7, 613 7 of 23
Processes 2019, 7, x FOR PEER REVIEW 7 of 24 
 
 
Figure 3. Spain. Waiting times of patients for cataract surgery, trends since 2005. Source: Compiled 
by the authors based on Organization for Economic Co-operation and Development (OECD) Health 
Statistics 2018. OECD/EU (2018), Health at a Glance: Europe 2018: State of Health in the EU Cycle [9]. 
 
Figure 4. Waiting times of patients for hip replacement, trends since 2005. Source: Compiled by the 
authors based on OECD Health Statistics 2018. OECD/EU (2018), Health at a Glance: Europe 2018: 
State of Health in the EU Cycle [9]. 
In 2016, the average waiting time for people who underwent hip replacement surgery in Spain 
was around five months. The waiting time for hip replacement surgery increased from 117 days in 
2005 to 158 in 2016. In 2011, the decreasing trend that begun in 2006 ceased and the waiting time 
started increasing [9]. 
3.10. Readiness of National Health Data Governance Frameworks to Support the Use of Electronic Health 
Record Data 
Electronic Health Records (EHRs) are used by 100% of primary healthcare doctors in Spain, and 
according to the Ministry of Health data, in February 2019, 91.99% of prescriptions in Spain were e-
prescriptions. E-prescribing allows doctors to write prescriptions that can be retrieved by a pharmacy 
electronically [14].  
In 2016, the OECD Health Care Quality Indicators Expert Group conducted a study of 30 
countries to explore the data governance and technical and operational factors that would support 
i . i i t si .
t ti ti . / ( ), lt t l : : t t f lt i t l [ ].
 , , x FOR PEER REVIEW 7 of 4 
 
 
Figure 3. Spain. Waiting times of patients for cataract surgery, trends since 2005. Source: Compiled 
by the authors based on Organization for Economic Co-operation and Development (OECD) Health 
Statistics 2018. OECD/EU (2018), Health at a Glance: Europe 2018: State of Health in the EU Cycle [9]. 
 
Figure 4. Waiting times of patients for hip replacement, trends since 2005. Source: Compiled by the 
authors based on OECD Health Statistics 2018. OECD/EU (2018), Health at a Glance: Europe 2018: 
State of Health in the EU Cycle [9]. 
In 2016, the average waiting time for people who underwent hip replacement surgery in Spain 
was around five months. The waiting time for hip replacement surgery increased from 117 days in 
2005 to 158 in 2016. In 2011, the decreasing trend that begun in 2006 ceased and the waiting time 
started increasing [9]. 
3.10. Readiness of National Health Data Governance Frameworks to Support the Use of Electronic Health 
Record Data 
Electronic Health Records (EHRs) are used by 100% of primary healthcare doctors in Spain, and 
according to the Ministry of Health data, in February 2019, 91.99% of prescriptions in Spain were e-
prescriptions. E-prescribing allows doctors to write prescriptions that can be retrieved by a pharmacy 
electronically [14].  
In 2016, the OECD Health Care Quality Indicators Expert Group conducted a study of 30 
countries to explore the data governance and technical and operational factors that would support 
t f i re l c t, t si c 20 .
/ ), lt r e :
3.10. Readiness of National Health Data Governance Frameworks to Support the Use of Electronic Health
Record Data
Electronic Health Records (EHRs) are used by 100% of primary health are doctors in Spain, and
according to the Ministry of H alth d ta, in F bruary 2019, 91.99% of prescriptions in Spain wer
e-pr scription . E-prescribing allows doctors to write prescriptions that can be retrieved by a pharmacy
electronically [14].
In 2016, the OECD Health Care Quality Indicators Expert Group conducted a study of 30 countries
to explore the data governance and technical and operational factors that would support them in
the development of national health information and research programs from data held within EHRs.
The study explored several key indicators of the readiness of national health data governance
frameworks to support the use of EHR data to fulfil national health information and research objectives.
These indicators include: (1) having a legal framework that allows data within EHR systems to be
extracted for statistical and research purposes, subject to suitable safeguards; (2) having a national
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EHR plan or policy that includes the statistical and research uses of these data; (3) engaging in the
extraction of data from EHR systems to create national datasets; and (4) analyzing data extracted from
EHR systems for key national monitoring and research objectives. According to this study, Spain is far
from the most advanced countries: Canada, Denmark, Finland, New Zealand, Singapore, Sweden,
the United Kingdom (England and Scotland) and the United States; although it is ahead of countries
such as Australia, France, and Japan [15].
4. Discussion
4.1. Main Challenges of the Spanish National Health System
The main challenges that the Spanish National Health System must face are the following:
1. The rising old age dependency ratio. This growing proportion of elderly people means
an increasing demand of healthcare services due to a prevalence of chronic diseases that will
cause an increase in health expenditure.
2. Health expenditure pressures and the likely increase of out-of-pocket expenditure.
3. Drug expenditures, both retail and consumed in hospitals.
4. Waiting lists for surgery.
5. The percentage of potentially preventable hospital admissions.
6. The use of EHR data to fulfil national health information and research objectives.
4.1.1. The Rising Old Age Dependency Ratio
The National Health System has a limited influence on the first of the challenges. The answer
to these challenges lies in government policies in the areas of social services and labor conditions
among others. Although the National Healthcare System cannot influence on this challenge, it can
and must manage its consequences. The aging of the population produces higher morbidity and more
chronic diseases, which cause a higher usage of health services. Therefore, the quality of attention
that chronic patients receive must improve in order for them to improve their self- care and control,
to avoid hospital stays, and to lower the usage of primary care centers.
4.1.2. Healthcare Expenditure Pressures and the Likely Increase of Out-of-Pocket Expenditure
Although the Independent Fiscal Authority expects an increased public health expenditure rate of
4% during the next few years, the uncertainty on the level of economic growth entails that public health
expenditure is not likely to increase. However, the increase in population over 65 is very likely [16].
This challenge threatens the accessibility to healthcare services because the out-of-pocket
expenditure increase coincides with the public health expenditure decrease. At an aggregate level,
the share of out-of-pocket spending in total health spending reflects the degree of financial protection
in a country along the three dimensions of coverage—the share of the population covered, the range of
services included in a public benefit basket, and the proportion of costs covered by collective third-party
payer schemes for each service [9].
4.1.3. Drug Expenditures, Both Retail and Consumed in Hospitals
Spending on medicines in Spain currently comprises 25% of the total health expenditure.
The increase in drug expenditures is a complex phenomenon influenced by various related factors.
The aging of the population together with the increased prevalence of chronic diseases and the increase
in drug prices caused by the continuous introduction of new and more expensive drugs are factors that
help explain it. However, others are just as important, such as clinicians’ way of practicing medicine;
the organization of the health system, which may have ways to control or influence drug prescription;
the existence of guidelines; the degree of generic penetration in pharmaceutical consumption; and the
work of pharmaceutical commissions, which analyze and decide on the incorporation of new drugs to
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the drug formulary of hospitals. The drug industry has a notable effect on increased expenditures by
regularly introducing new active principles to the market, some arguably without added value over
existing ones and with a higher price [17].
More than 13,700 pharmaceutical products were in the pipeline in 2016, of which nearly 6900 were
in a clinical phase of development. Oncology is by far the most targeted therapeutic area, representing
almost one-third of the medicines in development in 2016, followed by prophylactic vaccines and
anti-infectives, and antidiabetics [15].
4.1.4. Waiting Lists for Surgery and the Preventable Hospital Admissions Ratio Represent Two Quality
Issues That Also Should Be Considered
Waiting times are the result of a complex interaction between the demand and supply of health
services. The demand for elective surgery is determined by the health needs of the population, progress
in medical and surgical technologies, and patient preferences. On the supply side, the availability
of surgeons and other staff in surgical teams, as well as the supply of the required equipment and
the occupation of beds in hospitals affect surgical activity rates [9]. Waiting lists are a long-standing
problem that has proven to be very sensitive to fluctuations in the volume of public health expenditure.
The increase in waiting lists in Spain since 2011 has coincided with the decrease in public spending
(Figures 2–4). This situation reflects a weakness in the efficacy, efficiency, and quality of the health system.
Reducing the rate of potentially preventable hospital admissions, which in Spain is above the EU
average, requires improving the care of people with chronic conditions. This is a very important task
as the number of patients with chronic conditions is expected to rise. Better indicators about caring for
chronic conditions are not available.
4.1.5. The Use of EHR Data to Fulfil National Health Information and Research Objectives
The foregoing leads to the need to improve the efficacy, efficiency, and quality of the health system.
As noted above, IT brings improvements in efficiency and quality of operations management in health
systems by reducing operating costs of clinical services, reducing administrative costs, and enabling
entirely new modes of care. Health data constitutes a significant resource to improve population health
and the effectiveness, safety, and patient-centeredness of healthcare systems. Spain does not have
national legislation or regulation to allow extraction of data from the national EHR system for national
research or statistical purposes. As a result, databases must be administered by each Health Authority
(region). Spain also faces data governance barriers that limit researchers’ access to electronic clinical
data. These include a strong bureaucracy and a lack of written policies regarding how applicants may
apply for access to data within EHR systems. Some IT providers are reluctant to provide access to data
for research and/or apply financial charges for accessing data that may limit data accessibility [15,18].
All these circumstances make it necessary to develop a Big Data system for the National Health
System of Spain.
4.2. A Big Data Solution for the National Health System of Spain
As listed along this article, the current challenges of the Spanish National Health System have
been identified through a list of indicators obtained from the exhaustive analysis and monitoring of
a heterogeneous set of data sources. Most of these sources are in fact provided by the National Health
System, so it is in its hands to better understand and manage these data for the efficient use of the
system’s resources. This section applies the principles and criteria analyzed so far to draft a proposal
on a Big Data System for the National Health System of Spain (BDNHS).
4.2.1. Big Data Principles
The idea of “data-driven innovation” (DDI) that refers to techniques and technologies for processing
and analyzing large volumes of data, which are commonly known as “Big Data”, is becoming an
important resource that can lead to new knowledge, drive value creation, and foster new products,
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processes, and markets. DDI is a source of economic growth and development through two distinctive
“channels”: [19]
1. The economic properties of data suggest that data is an infrastructure-like resource which in
theory can be used by an unlimited number of users and for an unlimited number of purposes as
an input to produce goods and services.
2. The value-creation mechanisms of data analytics, which include using data analytics to:
• gain insights (knowledge creation)
• automate decision-making.
The concept of Big Data, commonly misused, should only be applied to datasets which exceed
the capacity of common software tools regarding volume, speed, and variety of data, among others.
The relation of Big Data with data mining and knowledge management can enlarge the concept of Big
Data to establish at least three fundamental characteristics of Big Data solutions:
• The use of high-performance IT infrastructure regarding the capacity of information management
in terms of volume, speed, and variety.
• The extraction of information as a result of large-scale data processing.
• The generation of knowledge from that information and its use for the strategic management of
an organization.
The first goal when analyzing large datasets in health services is to provide the best possible
information to those in charge of decision making: doctors, managers, and other health professionals.
Health organizations must use data to reach their own goals as well as those of the people they are
aiding. Therefore, data use must be oriented towards generating value for each patient and for the
health system itself. This activity should also be directed towards anticipating the needs and preferences
of patients and planning the services they could require, such as in the case of chronic patients who
should receive personalized treatment.
The patient must always be the center of any health system and, as such, of the health information.
When employing these tools, medical practitioners must be aware of the expected turnaround and of
whether their patients are receiving the right care in the right moment. Managers of health organizations
must also be empowered to make decisions by receiving the right information, so they can plan ahead,
set targets, and make real time corrections [20]. Knowledge generated by health systems can be defined
as an integrated entity in which science, IT, and health assistance services join forces to generate outputs
derived from health services.
Data related to health systems may be classified in one of the following three categories:
• Traditional: stored in clinical records and department files.
• Data generated by patients and citizens: patient reported outcomes, social networks, devices, and
individual sensors
• Omics data: obtained from molecular biology.
Individual clinical information contained in EHRs has some limitations, as it does not include
over the counter drugs; data on lifestyle habits, such as sleep, diet, or physical activity; environmental
risk factors; and information from the perspective of the patient or his/her priorities. Health outcomes
reported by patients could be used in clinical trials to monitor their efficacy and security. To make use
of a resource that provides real world data it should incorporate resources generated by patients on
social media, apps, sensors, wearables, direct services to consumers, polls, and questionnaires.
Human gene sequencing and the systematic analysis of other individual profiles are currently
generating new data, known as omic data. Most EHRs can only include that type of data as
a non-structured report, and it would therefore be hard to use in aggregated studies. Future
compilation of multi-omic data will require standard representation formats, and the use of such data
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in clinical practice will need support systems to clinical decisions and new ethical guides. Genetic and
omic individual information plays a key role in the concept of precision medicine, as it is commonly
known in the US, or personalized medicine, the term adopted in the European Union [21].
Precision medicine promises to provide the right treatment at the right time, every time, to the
right person. It employs information on genes, proteins, and other pathologies of a patient, his/her
lifestyle, prescribed drugs, health condition, and environmental factors in order to determine the
diagnostic or treatment of the disease. The main field of application is oncology, because it can act on
the changes that promote the growth, division, and dissemination of cancer cells. Precision Medicine
has the potential to radically transform medicine and healthcare, because it consists on individual
treatments for individual patients and promises to be more effective and safer than existing ones.
Biomonitors to select patients are being analyzed for the use of new drugs, to adapt the administration
of drugs, and to control adverse effects.
The health ecosystem is a concept even wider than the health system itself, since it consists of
a set of entities that can become a patient-focused cluster or even a hub, if they take advantage of the
synergies they produce. These entities are, among others, healthcare centers and services, universities,
research centers, health industries, and the public administration. They generate and process health
related information, and they must all be considered when it comes to the production of knowledge,
which will improve the overall system.
The use of clinical data together with other large datasets provides a great opportunity for the
improvement of the quality of health assistance, plus investigation, education, and epidemiological
awareness. The aggregated data related to a disease or treatment enhances its effectiveness and quality
and improves cost-control and efficiency. They can be especially useful to make decisions related to
funding treatments and setting the cost of drugs. The link of biological data with clinical, environmental,
and demographic data will improve epidemiological knowledge of chronic and infectious diseases.
An example of Big Data application in healthcare is population segmentation, by linking
information from different sources, such as primary care, specialized care, and pharmacies, to develop
projections of the likely evolution of a group of patients and plan their treatment in terms of demand,
risk, resources, and costs. This process is especially interesting in the case of chronic patients, so they
can get thorough tests related to certain diseases, which are a priority for healthcare organizations
as they entail an important risk for these patients. Another example is the case of high frequency
patients at primary care services: those that go 12 or more times per year. Big Data can help unwind
the patterns of these visits and treat them in a more efficient way.
The incorporation of data from different sources will allow the advance towards personalized
medicine by creating advanced systems for clinical decision making, thanks to the combination of
clinical, genomics, and environmental information. It will also allow managers and public health
systems to make more informed decisions. Lastly, it will introduce great changes in research, by studying
data obtained from large pools instead of study groups. The end goal of these three processes is for
clinical decision making to be predictive, personalized, preventive, and participative (Figure 5) [22].
Patient’s phenotyping consists on identifying individuals which coincide with clinical investigative
criteria. There are already methods in place for automated phenotype. When these systems are employed
for selecting patients eligible for a clinical trial, the relevant characteristics are derived from the data
of medical records which can be used for answering investigation lines. Since many countries have
electronic records in their public services, new studies could be carried out by linking data of individuals
from two or more sources. This must be done taking into consideration the privacy of patients [23].
For pharmaceuticals, there is an expectation that judicious use of “real-world data” (RWD) will
make all steps in the development and use chain more effective and efficient, including research
and development (R&D), regulatory decision making, health technology assessment (HTA), pricing
and reimbursement decisions, and treatment. The increased opportunity to analyze RWD and the
development in analytics methods will undoubtedly create many advantages for patients. Increased
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focus on the importance of patient involvement and the widespread discussion on patient insight and
engagement will complement the technical developments [18].Processes 2019, 7, x FOR PEER REVIEW 12 of 24 
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Big Data systems will allow real data evaluation a d public health improvemen , as well as
considering social conditioners of health by gathering data from EHRs, w ich will progressiv ly
incorporate more information towards those goals [24].
In a dition to the secondary us of patient dat for clinical research a d healthc re, ther are other
applications, most of which are halfway betwe n EHRs and genetics. In this aspect, biorepositories and
biobanks play a key role in generating data for a potential secondary use. Data repositories originating
from clinical attention are accepted as a complimentary source of randomized clinical trials. This way,
clinical research extends to real world evidence, which evaluates effectiveness and security during
common clinical practice.
The future aggregation of omics and environmental data will require standard formats, support
systems for clinical decisions, and new ethical and legal guidelines.
4.2.2. Data Acquisition
The main challenge in a project which employs large health related datasets consists of determining
which are that data, how they can be intertwined, and what is their value. This decision must be made
in a structured and unanimous way, and with explicit and objective criteria on quality, accessibility,
and structure. Organizations must deal with issues such as integrating structured and quantitative
data with non-structured qualitative sources, determining the data provenance, and the fragmentation
of digital health records and proprietary syst ms, which makes intero erability m re difficult.
The process of nalyzing inform tion begi s with th s lection of necessary data. This data
co responds to multiple reas, so they will be stored in different systems and atabases, each of which
will have its ow structure. Before entering the system, this data must undergo a quality control
that determines:
• If the data is compatible with the system (format and compatibility).
• If the data responds to existing needs (suitability and appropriateness).
• If the data is complete (completeness).
• If the data is valid (integrity and consistency).
• If the data is detailed enough (precision and accuracy).
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• If the data is structured in a way that the system can process (standardization and normalization).
Data meeting the requirements of quality control can then undergo a pre-processing phase that
may include modification of its original structure, indexing to stablish existing relations between them,
and final storage in the repository of the system (Figure 6).
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Lastly, users performing data analysis can access the data safely, undertake required operations,
and interpret the results of the process, which generates new knowledge. The access to health records
must be conceded based on the purpose of using the data rather than on the type of user. The model
proposed by health systems entails that the data registered during assistance helps improve the process
and obtain greater information on diagnosis and therapeutic options. Investigators will obtain real
world data, which will improve the execution of clinical trials and make them more pragmatic and
adaptative. Therefore, these trials will study, not just the efficacy, but also the effectiveness of new
therapies (Figure 6).
One of the main aspects of information systems is the design of datasets and metadata, because it
has a large influence on the entire storage, organization, and analysis of information. The structure of
a database must bring the right level of detail for every data. The model of data in a project such as
EHRs must consider the combinations of structured and non-structured data and find a better way to
incorporate these in an efficient and effective way. Therefore, this aspect leads to the combined use of
NoSQL databases, and of tools such as natural language processing [25]. These are especially relevant
for structuring data originating from EHRs. Another relevant aspect is the fact that tools for Big Data
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analysis are so specific that each project requires a combination of specific technological tools that once
integrated give a global response to all needs of the system. For instance, a critical or time-sensitive
system must resort to real time technologies.
One of the first steps in these projects is to make an inventory of the different datasets available
with a detailed description by using metadata, which includes codes or standards which must be
employed to guarantee semantic interoperability. Widely used standards are especially relevant in the
case of federated systems because their managers must decide if the data is combined or stays separate.
Data safe havens are focused on trust, reliability, fulfilling legal and ethical criteria, and the
management and publishing of data within socially acceptable limits. The criteria can also be related to
trust, integrity, and availability, as well as an adequate and safe access point. Data safe havens have well
defined governance systems, their safety is trusted, and the result of its investigations is transparent.
During the initial phases of the project the independent character of the regulatory body of the
project must be established, which extends its control over the usage of the data by the public health
system. This body must arrange the requirements for joining and signing the agreements with the
entities that agree to share the data once it is decided that they fulfil the requirements.
4.2.3. Treatment of Data
Data governance can be defined as the management of data in terms of accessibility, availability,
usage, integrity, and quality. The key is to be able to easily store data in available repositories, but also
with the appropriate technical and government controls, auditable and audited in an effective way, and
deemed trustworthy to all interested parties. The approval and kick-off of Data Health Systems requires
an explicit compromise by the stakeholders of the national health system and must be controlled by
a committee or specific working group.
The application of Big Data to the analysis of large datasets is based on two principles: first,
health centers must have interoperable EHR, and second, the metadata must be made available by
health systems. They must have a series of technological, semantic, and organizational standards that
allow the exchange of health information keeping the coherence of meaning of the data.
The logic architecture of the system, that is, the conceptual scheme that describes its components
and the relations between them must be coherent with the established governance of the data.
Depending on the final structure of the system, there are two main types of architecture:
• Centralized: it comprises a central node that works as the sole repository of the system data.
This requires implementing a process for storing new data as they are generated, so that they are
available for consultation and analysis by users of the system.
• Federated: each provider data center is at the same time the repository of its own dataset, which it
only shares with the rest of the nodes of the system on demand, that is, when that data is required
for analysis.
No model is better than the other. Instead, their advantages and disadvantages must be examined
on a case by case basis. The main requirements regarding the adoption of standards and the capacity of
growth and evolution must be applied on equal terms to centralized and federated architectures so that
timely access to data with the required format is guaranteed. For instance, real time applications will
benefit from centralized architecture, because it lowers the response time since all data compilation is
done in advance. However, federated architecture can be more interesting for projects involving more
than one organization, so that they can protect their own information and have absolute certainty that
only what it strictly necessary will be shared.
A mixed model can also be adopted, which uses one method or another depending on the nature
of each case. This possibility combines using a centralized repository for data whose analysis might
be time sensitive, such as consulting a support system for making clinical decisions in the midst of
a medical consultation, with using federated databases for information whose analysis does not require
a quick execution, such as massive analysis of data for a clinical investigation project.
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A data health dictionary containing a description of the archives available on the database must
also be created. This will become a fundamental tool for anyone interested in accessing the content of
the database. With this instrument, users can search the databases, filtering categories or record types.
The expected workflow of Data Health Systems anticipates that users with a research question will
search on the data dictionary the availability of the data they require. After that, they must complete
the research protocol on one of the available forms of the system. The next step is to obtain approval
by the governance units to ensure the study is adequate and compliant with the existing regulation.
Afterwards, the technical teams must prepare the data processing and its mapping with standard
codes. Once the data is ready and its quality has been checked, it must be analyzed, and the results
made available. If anonymized data contains any form of tracking that allows for its identification,
there must be a frame for minimizing that risk.
All protocols for accessing the system must be easy to understand, available online, and transparent.
Organizations as well as individuals must be certified and prove that they have the technical means
to guarantee the safety of data. Any strategy to reduce risk according to the secondary use of data
must be based on the improvement of the capacities of the users of the systems, and not on making the
access more difficult with more complex and restrictive protocols.
There must be a balance between the best possible design of the studies and the practical aspects
which make it possible, such as the data load and the costs associated to the participants.
Lastly, it is fundamental that each actor, including both institutions and individuals, may access
and analyze data in a safe, effective, and efficient manner.
4.2.4. Data Interoperability
As mentioned, data homogenization is a key process to achieve the integration of the different
sources and the semantic interoperability of the involved information systems [26]. The use of extended
standards to represent and manage both captured and produced datasets will allow proper data
analysis, provide a wider set of tools to process information and support further reuse of the outcomes.
This way, the standardization of the data flow, at all levels of the health system, is of utmost importance
to produce valuable results.
Standards in data management related to health systems apply to three different levels:
• Messaging standards (for data communication). These standards define the way the different IT
systems communicate with each other, providing a set of rules that guarantees that the exchanged
information is solid. These rules set the format, structures, and data types that build each of
the allowed messages to be shared among the tools within the system and to communicate
with external ones. Digital Imaging and Communications in Medicine (DICOM) [27] for digital
imaging or Health Level Seven (HL7) [28] are two of the most used ones in worldwide health
systems interoperability.
• Documentation standards (for human communication). If messages are intended for digital
systems, documents structure information to be managed by humans. In a health system, everyday
hundreds of documents are filled and read by professionals. These documents reflect, among
others, valuable information about the patients and the processes they are subjected to. Standards
here define common structures to capture and present information, from and to the system users.
In turn, these structures enable software systems to analyze and process the information, build
useful messages, and improve interoperability. Clinical Document Architecture (CDA® [29],
Continuity of Care Record (CCR) [30], and Continuity of Care Document (CCD) [31] are extended
clinical documentation standards.
• Terminology standards (to represent information). This set of standards provides a common
lexis to define, represent, and code medical concepts, such diagnosis, disease, medication, etc.
This health language will be later used to fill the clinical documents shared by the whole health
system. Systematized Nomenclature of Medicine – Clinical Terms (SNOMED CT) [32] or 10th
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revision of the International Statistical Classification of Diseases and Related Health Problems,
(ICD-10) [33] (for disease statistics) are two of the most relevant in this area.
The proper selection of the set of standards implemented to manage the information among all the
different levels of the health system will directly impact its interoperability, as well as the functionalities
offered to its users.
4.2.5. Bioethical and Legal Aspects
From an ethical point of view, quite a few similarities to the legal field can be observed. The fact
that IT is going to play an increasingly important role in health systems seems to be widely accepted,
since its potential as a key instrument for the transformation of the current model is appreciated.
Table 3 summarizes the key aspects that must be considered for a bioethical discussion [34].
Table 3. Key points to be considered in a bioethics discussion.
Precision and Validity of Data and Algorithms
Consent to data sharing and new ways to obtain them, such as automated sharing, voluntary communication,
amplified consent, or dynamic consent.
Confidentiality, which deals with the repercussion of coding or pseudo anonymization, and the anonymization
of data in the analysis of information, as well as the dilemma between right to privacy and public interest.
Source: León P. Key Points for an Ethical Evaluation of Healthcare Big Data [30].
Some ethical challenges are straightforward and need to be guarded against, such as concerns that
algorithms may mirror human biases in decision making. Others, such as the possibility for algorithms
to become the repository of the collective medical mind, have less obvious risks but raise broader
ethical concerns [34,35].
Patient’s rights must include the principles of respect to people, human rights, participation of
those with morally relevant interests, and the responsibility of the decisions taken. Precision and
validity of data and algorithms are fundamental to making the right choice.
Informed consent must be explicit and refer to the decision made on the information flow.
Specific consent must be granted for data processing, although secondary analysis can be performed
without an extra consent if the United Nations Educational, Scientific and Cultural Organization
(UNESCO) principles are respected: appropriate legal background, evaluation by the ethical and
research committee, public interest of the investigation, and impossibility of a new consent [36].
The right to privacy and public interest are intertwined. There are private interests in obtaining
public interest and public interest in privacy protection, which encourages cooperation. They must
both come to an agreement. In fact, the new European General Data Protection Regulation states that
it might be necessary to obtain data without consent for public interest reasons. The law allows for
pseudonymization, but it is hard to assure that anonymity can be preserved if different databases of
different provenance are combined.
The responsibility of health professionals and managers of the health system, which
extends to institutions, covers appropriate data analysis including its goals, quality, precision,
and statistical procedure.
The Advisory Panel of Experts on Health Information Infrastructure (OECD Health Committee)
identified key data governance mechanisms supporting privacy-protective data use [6]:
1. The health information system supports the monitoring and improvement of healthcare quality
and system performance, as well as research innovations for better healthcare and outcomes.
2. The processing and the secondary use of data for public health, research, and statistical purposes
are permitted, subject to safeguards specified in the legislative framework for data protection.
3. The public are consulted upon and informed about the collection and processing of personal
health data.
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4. A certification/accreditation process for the processing of health data for research and statistics
is implemented.
5. The project approval process is fair and transparent and decision making is supported by
an independent, multidisciplinary project review body.
6. Best practices in data de-identification are applied to protect patient data privacy.
7. Best practices in data security and management are applied to reduce reidentification and
breach risks.
8. Governance mechanisms are periodically reviewed at an international level to maximize societal
benefits and minimize societal risks as new data sources and new technologies are introduced.
4.3. Proposal for the Learning Health System of Spain
Although the essential principles of the National Health System of Spain are universal coverage
and public funding of the system via taxes, it is also defined as an integrated health system which
provides both primary as well as specialized care. This task is undertaken by public employees in
public institutions, and under the management of regional health systems.
The information services of the health system reflect this decentralized nature, although the
Ministry of Health is responsible for the systems and information technologies shared by all health
services. An Inter-territorial Board of the National Health System in which all the regions that take
part oversee the coordination between the healthcare providers. It is tasked with acquiring knowledge,
debating, and advising on the essential functions of the National Health System, and planning,
coordinating, and evaluating its performance.
All healthcare services in Spain have EHRs. They add efficacy, efficiency, and safety to the health
attention process. They register essential data such as age, sex, diagnoses and procedures, prescribed
drugs, and the results of explorations, among others. All regions register public health records,
prescription drug usage, and labor and environmental health. The EHR also provides information on
adverse medication effects among other relevant registries for the Health System. All this information
helps build a system which allows the analysis of all these sources to benefit patients, the health system,
researchers, and society.
4.3.1. Data Acquisition and Traceability
According to the report on the implementation of the interoperable EHR of the National Health
System, in 2017 36,193,454 citizens had references with available contents, which accounts for 77.88%
of the population [37].
Despite that, the system aims to make medical records accessible to patients and health
professionals in the assistance process. The system is not conceived for investigation purposes,
but for generating assistance documents on demand and in relation to specific patients.
In order to use information for research purposes it would be necessary to implement a more
detailed data structure, allowing for more precise information management and selection, such as
the selection of specific groups of patients; and apply a number of measures to guarantee safe access
to that data, such as anonymization in accordance with existing laws covering clinical investigation.
It would also be convenient to complete the information with other types of non-clinical data, such as
environmental, which could be potentially relevant in a research project.
The information contained in medical records that can be found in EHRs of healthcare systems
should be updated, and it should register the information generated by patients. The use of that data
requires an architecture backed by structured and coded data. These applications require merging
data from different sources. The result is a specific database which can be accessed via safe access
when necessary.
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4.3.2. Architecture Overview
Most of the main functionalities and building blocks of the presented Spanish Learning Health
System have already been described in previous sections. This part summarizes the authors’ approach
into a holistic technical architecture that would guide a preliminary implementation for the introduced
solution. This architecture is composed of three main layers, each of them capable of being implemented
in a centralized, distributed or combined manner, addressing three different stages on data gathering,
data processing, and data exploitation.
• Layer 1: Data Gathering and Data Homogenization
Big Data principles show the relevance of standardized data capturing and the different processes
needed to guarantee quality, consistency, and compatibility. This layer implements all required
connectors to the different heterogeneous data sources that filter and convert information, providing
layer two with homogeneous and standard datasets. Most of the integration capabilities of the final
solution will rely on the connectors set here.
• Layer 2: Big Data and Machine Learning
The core of the proposed system will be composed by two main blocks: the Big Data tools, that
classify, organize, and store all captured data; and the machine learning environment implemented,
which includes the algorithms and neural networks, fed by the Big Data tools, that train the whole system
and make it “learn”. This layer will produce most of the relevant outcomes of the Learning System.
• Layer 3: Presentation and Data Analysis
Finally, the presentation layer will expose the processed results, as well as all captured and classified
health information. Through different data warehouse solutions, clinic workstations, and further
connections to specialized data analysis tools, these results will generate and present new valuable
medical knowledge to improve the efficiency of the whole Spanish National Health System.
4.3.3. Road Map
The main stages for implementing the BDNHS are summarized in Table 4.
The project must have full institutional backing to guarantee its acceptance and the participation
of all health services, universities, research centers, and scientific societies.
Other than being explicit, the backing must also translate into awarding the necessary budget
at least for the first two years of the project. Project managers must also look into funding sources,
which should add to institutional funding additional sources such as European Union grants.
A project of this nature must count on a team of professionals coming from different disciplines
such as clinicians, researchers, managers, health system experts, health IT experts, lawyers, and
bioethics experts.
The project manager must respond directly on the development of the project to the Ministry and the
Interregional Council. The project team must have Ministry and regional representatives, and it would
be recommended to have other entities of the health system take part, such as professional associations,
scientific societies, IT company clusters, research and teaching centers, and patient associations.
The operational targets require defining the different applications that the BDNHS intends to
cover, because its deployment must be compatible with clinical assistance, and health services’ research
operations and day to day management. These environments have different needs and procedures,
so they must compromise on solutions that allow the harmonization and tend to the requirements of
them all.
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Table 4. Road map for a Big Data System of the Health System of Spain.
Step Phase Description
1 Approval by institutions The project must be approved by the Health Ministry and theInterterritorial Board, who must explicitly back it.
2 Budget funding The project must be awarded a budget. It will be covered with Ministry andregional funds and other sources, such as EU funds.
3 Project team selection The team will be comprised of scientific groups, patients, and researchcenters, among others.
4 Operational goalsdefinition
The following goals must be considered: clinical assistance, investigation,
and management of health services and systems.
5 Digital health platformcreation An online bio health center dedicated to digital health must be created
6 Legal and institutionalframe
Government units, task units, procurement, agreements, and partnerships.
Ministry and Interterritorial Board accountability. Data protection rules,
biomedical research, intellectual property.
7 Technical requirementsdefinition
Definition of data modeling. Data protection rules.
System architecture model
8 Information security plan
System Access control. System Access registry. Information use control.
Registry of information. Access, auditing of system access and data use.
Information integrity. Information availability
9 Technical proposal Technical proposal that details the necessary steps for systemimplementation
10 Management Management groups, with Ministry of Health and regional representatives.Usage rules. Protocols to access and use data
11 Pilot execution Required to optimize developed tools
12 Global evaluation Use of the system and impact on efficacy, effectiveness, and efficiency of theNational Health System, which should impact the health of the population
In order to obtain results in the short-term realistic milestones must be set. This would allow
all parties to quickly profit from the effort and investment undertaken, evaluate the impact of the
measures under implementation, reinforce trust and compromise among clinicians, bring benefits to
patients, and overall, add value to the project.
There is currently no net devoted to digital health, nor a reference center in terms of health IT
research in Spain. One of the critical factors for the success of the BDNHS is to count on a critical mass of
experts in the integrated management of, among others, clinical, socioeconomic, and environmental data.
Therefore, it is critical to create a net dedicated to IT health, as well as educating specialists in the field.
There are two areas that fall under legal analysis in this project. The first one refers to the
legal nature of the BDNHS management unit, because it should not be part of the basic public
administration structure. Instead, it should be an entity with autonomous management capacity,
although closely related and controlled by the Health Ministry and Health Services. On the other hand,
a thorough analysis of existing legislation covering data protection must be undertaken to consider
the requirements and restrictions on information usage. Another relevant aspect is the legal frame
that governs clinical investigations, which could require changes depending on the applications and
mechanisms defined on the BDNHS.
Intellectual property must also be examined regarding the results of the BDNHS. Participating
institutions must undertake a large investment. Their goal is that the resulting system works as
fundamental support to the transformation, improvement, and sustainability of the current health
system. However, an additional result could be the offering of services to third parties, such as private
healthcare providers, research centers or health-tech companies, among others. All proposals to modify
existing patient rights and data protection must consider the bioethical aspects of data treatment.
Among the requirements for the system, the following three aspects stand out:
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1. The definition of the BDNHS data models, considering the diversity of data that will be used;
the information sources that will provide that data; and the use of that data inside the BDNHS.
2. The standards policy on data management: acquisition, standardization, storage, exchange,
and processing, among others.
3. The election of a model of architecture for the system, which could be federated, centralized or
hybrid. However, the most appropriate final architecture could end up being a hybrid model,
with a centralized repository for clinical information, whose data structure would have a high
degree of similarity, and federated repository for nonclinical information, which would cover
diverse data originating in different sources.
Health data has the largest available protection from a legal point of view in the EU. Therefore,
an essential aspect of the BDNHS project must be the definition and application of a security plan for
the information that guarantees upholding existing rules. This plan must define measures related to
the control and registry of system access and information use, auditing of system access, and use of
data, and integrity of information through data quality control and security copy mechanisms. It must
also assure the availability of information through mechanisms of redundancy of backing measures
that can be quickly activated in case of partial or complete failure of the main system.
All previously mentioned technical aspects must be integrated in a technical proposal that details
the existing steps necessary to implement the BDNHS.
From an organizational and institutional point of view, the procedures that are needed to govern
and manage the system resulting from the project must be defined once it is implemented and put to
work. The governing bodies must be defined, as well as its internal rules and the protocols that will
govern the access and use of existing data.
It is also necessary to run a pilot in a defined and controlled environment with an adequate
size that allows obtaining conclusions on the functioning of the BDNHS. Every time an element or
component is introduced managers must take into consideration the need to run a pilot, and, if required,
its reach. A new element or component must be defined as a type of data, an information source,
a use of that data, or a region, among others.
One of the key aspects for the BDNHS to add value is the evaluation of the results obtained from
the project. The main elements to take into account are the use of the system and its impact on the
efficacy, quality, efficiency, and effectivity of the NHS, which must translate into an impact on the
health of the population. The evaluation must take place periodically, with the goal of checking the
evolution of these parameters.
4.3.4. Critical Success Elements
The following elements are considered critical for the success of the project:
1. The leadership of the Ministry of Health, which will allow the resistance that the regional health
service could present to be overcome, by assigning a budget and handling the legal requirements
for the creation of the bodies of the project, as well as modifying data protection rules and health
research if necessary, and taking care of intellectual property matters.
2. The agreement of the Interregional Healthcare Council creating the BDNHS, explicitly backing it
and taking over the compromises required: data provision, and resource and budget allocation.
3. The granting of a budget allowance for at least the first two years of execution of the project.
4. The creation of a management body for the project, whose team must be comprised of renowned
professionals with leadership skills. The director must have an executive profile but with flexibility
and negotiating skills to reach agreements between the stakeholders of the project.
5. The implication of all the Regional Health Services that comprise the National Health System of
Spain, who must obtain value in the short term in order to promote and reward their participation.
6. The training of professionals of the participating entities in IT health in order to have the best
available human resources to execute the project.
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7. The creation of a management unit that will extend its control over data usage to improve public
health as well as the health system. This management unit must determine the standards for
joining the program. It must also sign the required agreements with the entities that decide to
share their data once it is accredited that they comply with the requirements. This unit must be of
permanent nature.
8. The choice of an architecture model that considers the organization, technical, and budget
conditions of the participants, especially those of the 18 regional health services.
9. The consideration and thorough application of the recommendations provided by bioethics
experts to provide trust to citizens and professional entities as well as patient associations.
10. The compliance with data protection rules and the review of existing Spanish legislation in order
to take advantage of the opportunities that it brings for projects such as the BDNHS.
11. The participation of patients in the project. This requires a communication plan as well as making
the project known to the broader society. The plan must convey trust regarding citizen’s privacy
in line with the previous two recommendations. Trust requires transparency regarding data
sources, their processing, usage, and results.
12. The achievement of short-term milestones, bringing early benefits to users, and providing returns
and visibility to the project.
5. Conclusions
The Spanish National Health System is facing various demographic, economic, and management
challenges that will force it to undergo a deep transformation of the existing model. These challenges
directly impact the healthcare quality and expenditure, causing an inefficient use of the overall system
resources. In turn, each of these challenges are linked to several well-identified indicators obtained from
the analysis of different heterogeneous datasets. In this sense, the awareness and traceability of these
indicators, as well as their control (when possible), will improve the efficiency and efficacy of the whole
health system, while also enhancing the quality of the services offered. One of the key aspects for the
success of this process is the creation of a Learning Health System which should optimize knowledge
generation and its capitalization by applying it to healthcare and health system management.
IT enablers are a fundamental tool to address the complexity and vastness of health data as well
as the urgency that clinical and management decisions require. Big Data solutions are a perfect match
for that problem in health systems.
The creation of the BDNHS entails following these requirements:
• Identifying the required data and their sources.
• Implementing a repository of data to compile it before its analysis.
• Defining an architecture model according to the needs of the health system.
• Incorporating data protection measures in accordance with existing rules and applicable
bioethics guidelines.
• Using the most adequate data tools for the defined system model.
• Creating the management unit required for putting the model to work and managing the system,
with participation from regional health services, strong institutional backing, and the required
budget allocation.
• Complying with bioethical legal and data transparency guidelines, and data processing and use.
In summary, the Spanish National Health System is under pressure to undertake major reforms.
For such purpose it can, and should, make use of existing technological tools which can serve as
a starting point to face these challenges, even though they are not enough to solve them all, as a means
to start the project that will result in a Learning Health System.
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